NEW HAVEN, Conn.--CuraGen announced that its Board of Directors has approved a two-for-one stock split of the company’s common stock on March 30. At that time, stockholders will receive one additional share of the stock for every share each owned at the close of business on March 15. The stock will begin trading on a split-adjusted basis on March 31.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
